Introduction

Head and neck cancer is an umbrella term. It typically includes:
  • Oral cavity cancers
  • Cancers of the pharynx (including the oropharynx, hypopharynx and nasopharynx)
  • Cancers of the larynx

Epidemiology

  • Incidence: 19.00 cases per 100,000 person-years
  • Peak incidence: 60-70 years
  • Sex ratio: more common in males 2.2:1
Condition Relative
incidence
Nasal polyps5.26
Head and neck cancer1
<1 1-5 6+ 16+ 30+ 40+ 50+ 60+ 70+ 80+

Clinical features

Symptoms

Referral criteria

NICE cancer referral guidelines for head and neck cancer suggest the following:


Laryngeal cancer

Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for laryngeal cancer in people aged 45 and over with:
  • persistent unexplained hoarseness or
  • an unexplained lump in the neck.

Oral cancer

Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for oral cancer in people with either:
  • unexplained ulceration in the oral cavity lasting for more than 3 weeks or
  • a persistent and unexplained lump in the neck.

Consider an urgent referral (for an appointment within 2 weeks) for assessment for possible oral cancer by a dentist in people who have either:
  • a lump on the lip or in the oral cavity or
  • a red or red and white patch in the oral cavity consistent with erythroplakia or erythroleukoplakia.

Consider a suspected cancer pathway referral by the dentist (for an appointment within 2 weeks) for oral cancer in people when assessed by a dentist as having either:
  • a lump on the lip or in the oral cavity consistent with oral cancer or
  • a red or red and white patch in the oral cavity consistent with erythroplakia or erythroleukoplakia.